3. Rapee RM, Creswell C, Kendall PC, Pine DS, Waters AM. Anxiety disorders in children and adolescents: a summary and overview of the literature. Behav Res Ther 2023;168:104376.
5. International Statistical Classification of Diseases and Related Health Problems (11th ed, ICD-11). Geneva (Switzerland): World Health Organization, 2022.
7. Söderquist F, Syk M, Just D, Kurbalija Novicic Z, Rasmusson AJ, Hellström PM, et al. A cross-sectional study of gastrointestinal symptoms, depressive symptoms and trait anxiety in young adults. BMC Psychiatry 2020;20:535.
8. Baumel WT, Mills JA, Schroeder HK, Neptune Z, Levine A, Strawn JR. Gastrointestinal symptoms in pediatric patients with anxiety disorders and their relationship to selective serotonin reuptake inhibitor treatment or placebo. Child Psychiatry Hum Dev 2023;Sep 2 doi: 10.1007/s10578-023-01586-x. [Epub].
10. Ataee P, Badiee H, Mohammadzadeh S, Moradveisi B, Roshani D, Nasiri R, et al. The relationship between obsessive-compulsive disorders and childhood chronic functional constipation. Acta Med Iran 2021;59:499–503.
21. Strisciuglio C, Martinelli M, Lu P, Bar Lev MR, Beinvogl B, Benninga MA, et al. Overall impact of coronavirus disease 2019 outbreak in children with functional abdominal pain disorders: results from the first pandemic phase. J Pediatr Gastroenterol Nutr 2021;73:689–94.
24. Yang J, Fox M, Cong Y, Chu H, Zheng X, Long Y, et al. Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity. Aliment Pharmacol Ther 2014;39:302–11.
26. Baysoy G, Güler-Baysoy N, Kesicioğlu A, Akın D, Dündar T, Pamukçu-Uyan A. Prevalence of irritable bowel syndrome in adolescents in Turkey: effects of gender, lifestyle and psychological factors. Turk J Pediatr 2014;56:604–11.
27. Berens S, Banzhaf P, Baumeister D, Gauss A, Eich W, Schaefert R, et al. Relationship between adverse childhood experiences and illness anxiety in irritable bowel syndrome - The impact of gender. J Psychosom Res 2020;128:109846.
29. Drukker M, Peters JCH, Vork L, Mujagic Z, Rutten BPF, van Os J, et al. Network approach of mood and functional gastrointestinal symptom dynamics in relation to childhood trauma in patients with irritable bowel syndrome and comorbid panic disorder. J Psychosom Res 2020;139:110261.
31. Sahan HE, Yildirim EA, Soylu A, Tabakci AS, Cakmak S, Erkoc SN. Comparison of functional dyspepsia with organic dyspepsia in terms of attachment patterns. Compr Psychiatry 2018;83:12–8.
35. de Bruijn CMA, Geijtenbeek A, Browne PD, Benninga MA, Vlieger AM. Children with functional gastrointestinal disorders with and without co-existing nausea: a comparison of clinical and psychological characteristics. Neurogastroenterol Motil 2023;35:e14591.
39. Machnes-Maayan D, Elazar M, Apter A, Zeharia A, Krispin O, Eidlitz-Markus T. Screening for psychiatric comorbidity in children with recurrent headache or recurrent abdominal pain. Pediatr Neurol 2014;50:49–56.
41. Rutten JM, Benninga MA, Vlieger AM. IBS and FAPS in children: a comparison of psychological and clinical characteristics. J Pediatr Gastroenterol Nutr 2014;59:493–9.
43. Sangari RS, Hashemi M, Salehi B, Yousefichaijan P, Rafiei M, Rezagholizamenjany M. Anxiety disorders in children with functional constipation: a case-control study. J Compr Pediatr 2022;13:e119997.
44. Torabi F, Hashemi M, Zamanian M, Shayganfard M, Yousefichaijan P. The prevalence of social anxiety in children with chronic functional constipation. J Compr Pediatr 2023;14:e132384.
50. de Bruijn CMA, Rexwinkel R, Gordon M, Benninga M, Tabbers MM. Antidepressants for functional abdominal pain disorders in children and adolescents. Cochrane Database Syst Rev 2021;2:CD008013.
53. Lalouni M, Ljótsson B, Bonnert M, Ssegonja R, Benninga M, Bjureberg J, et al. Clinical and cost effectiveness of online cognitive behavioral therapy in children with functional abdominal pain disorders. Clin Gastroenterol Hepatol 2019;17:2236–44.e11.
54. Lalouni M, Hesser H, Bonnert M, Hedman-Lagerlöf E, Serlachius E, Olén O, et al. Breaking the vicious circle of fear and avoidance in children with abdominal pain: a mediation analysis. J Psychosom Res 2021;140:110287.
55. Roohafza H, Pourmoghaddas Z, Saneian H, Gholamrezaei A. Citalopram for pediatric functional abdominal pain: a randomized, placebo-controlled trial. Neurogastroenterol Motil 2014;26:1642–50.
57. Banihashem SS, Ghadikolaee AA, Sadeghi A, Rastegar R, Mirzaei M, Saber FY. Lifestyle modification for improving anxiety and depression among patients with irritable bowel syndrome. Gastroenterol Hepatol 2022;76:327–33.
58. Marczyńska P, Kowalkowska K, Kuczyńska R, Czerwionka-Szaflarska M, Krogulska A. [Evaluation of anger expression, school functioning and a level of anxiety in children and adolescents with functional abdominal pain]. Dev Period Med 2016;20:306. –14. Polish.
60. Von Gontard A, Moritz AM, Thome-Granz S, Equit M. Abdominal pain symptoms are associated with anxiety and depression in young children. Acta Paediatr 2015;104:1156–63.
63. Sjölund J, Kull I, Bergström A, Ljótsson B, Törnblom H, Olén O, et al. Quality of life and bidirectional gut-brain interactions in irritable bowel syndrome from adolescence to adulthood. Clin Gastroenterol Hepatol 2024;22:858–66.e6.